Cargando…
Assessment of elevated high-sensitivity troponin T to predict different mortality risks in patients with COVID-19
Autores principales: | Wang, Ping, Wang, Rong, Feng, Xue, Tang, Juanjuan, Zhang, Jiali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055378/ https://www.ncbi.nlm.nih.gov/pubmed/35500818 http://dx.doi.org/10.1016/j.ijcard.2022.04.077 |
Ejemplares similares
-
Elevated troponin levels predict the reduced efficacy of Paxlovid in COVID-19 patients
por: Zhao, Deze, et al.
Publicado: (2023) -
Admission High-Sensitivity Cardiac Troponin vs a Biochemical Score for Predicting Mortality in Patients With COVID-19
por: Kavsak, Peter A., et al.
Publicado: (2020) -
Cardiac enzyme (troponin levels) elevation in cardiac myxomas: Is it real?
por: Alizadehasl, Azin, et al.
Publicado: (2015) -
Issues Related to High-Sensitivity Troponin Assays
por: Tada, Masafumi, et al.
Publicado: (2022) -
Important Differences Between Manufacturers When Transitioning From a Contemporary Cardiac Troponin Assay to a High-Sensitivity Cardiac Troponin Assay
por: Kavsak, Peter A., et al.
Publicado: (2021)